The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome
{{output}}
It has long been acknowledged that the risk of cardiovascular disease is impacted by a complex interplay between the heart and kidneys. The relationship among cardiovascular disease, chronic kidney disease, and metabolic diseases, including obesity and diabete... ...